Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., | ![]() Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ![]() Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | ||
Founding Date | Founding Date 2002 | Founding Date 2000 | Founding Date 1999 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Incheon, KR HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Needham, US HQ | Locations Écully, FR HQ Cambridge, US |
Employees | Employees 6301% increase | Employees 999 | Employees 50 | Employees 402% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 648.3 m | Valuation ($) 176.8 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) ₩2t (FY, 2022) | Revenue (est.) €53.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ₩1.4t (FY, 2022) | Cost of goods €64.3m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ₩664.7b (FY, 2022) | Gross profit (€2.6m) (FY, 2023) | Gross profit N/A | Gross profit N/A |
Net income | Net income ₩147.2b (FY, 2022) | Net income (€260.2m) (FY, 2023) | Net income ($55.2m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1b | Total funding raised $ 64.6m | Total funding raised $ 93.1m |
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyCandel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View companyAmolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company